The Faculty has published guidance on the resumption of pain services following the disruption by the COVID-19 pandemic. This guidance highlights considerations to help achieve this reset locally. As part of this approach, the FPM will be reviewing progress through surveys and invites reports of experiences of all kinds.
The Faculty is pleased to support the recommendations issued by the NSUKI regarding the management of implanted neurostimulation & Intrathecal drug delivery devices during the COVID-19 pandemic.
The FPM has created a list of key challenges faced by pain services as a result of COVID-19 as well as selected statements and resources. This information is intended to support and enable best local decision-making and will be updated regularly.
The Faculty is pleased to note the timely publication of NICE Guidance NG144 on cannabis-based medicinal products